Bristol-Myers Squibb CompanyBMYNYSE
LOADING
|||
Cost of Revenue Over Time
Above historical average, strong compound growth.
Left:
||||
Direct costs attributable to producing goods sold
Latest
$20.87B
↑ 60% above average
Average (9y)
$13.05B
Historical baseline
Range
High:$20.87B
Low:$3.75B
CAGR
+21.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $20.87B | +6.2% |
| 2023 | $19.65B | -0.1% |
| 2022 | $19.67B | +0.2% |
| 2021 | $19.62B | -5.7% |
| 2020 | $20.82B | +134.0% |
| 2019 | $8.89B | +37.1% |
| 2018 | $6.49B | +11.5% |
| 2017 | $5.82B | +18.0% |
| 2016 | $4.93B | +31.4% |
| 2015 | $3.75B | - |